pocketful logo
Themis Medicare Ltd logo

Themis Medicare Ltd

NSE: THEMISMED BSE: 530199

₹82.17

(0.56%)

Wed, 11 Mar 2026, 03:15 pm

Themis Medicare Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    749.33

  • Net Profit

    29.83

  • P/B

    3.65

  • Sector P/E

    32.36

  • P/E

    45.26

  • EV/EBITDA

    23.81

  • Debt/Equity (Industry)

    0.23

  • Interest Cover (Industry)

    10.03

  • ROCE (Industry)

    12.82

  • RONW (Industry)

    12.23

  • ROE

    8.36

  • ROCE

    11.09

  • Debt/Equity

    0.25

  • EPS (TTM)

    0

  • Dividend Yield

    0.61

  • Book Value

    37.68

  • Interest Cover

    4.95

Analysis

all

thumbs up icon

Pros

  • Dividends paid are thoroughly covered by earnings (15.4x coverage).
  • Themis Medicare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Themis Medicare is profitable, therefore cash runway is not a concern.
  • Themis Medicare is profitable, therefore cash runway is not a concern.
  • Debt is covered by short term assets, assets are 2x debt.
thumbs up icon

Cons

  • Dividends per share have fallen over the past 10 years.
  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Themis Medicare's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Themis Medicare's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Debt is not well covered by operating cash flow (0.4%, less than 20% of total debt).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters67.1167.1567.1567.1567.15
FII0.050.060.000.140.10
DII0.010.010.010.010.01
Public32.8332.7832.8332.7032.74
Government00000

Read More

Technical Analysis

RSI

44.15

MACD

-2.43

50 DMA

88.22

200 DMA

111.52

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic127.35106.5096.1585.6575.3064.8043.95
Fibonacci106.5098.5493.6185.6577.6972.7664.80
Camarilla91.5389.6287.7185.6583.8981.9880.07

Pivots Level: Classic

R3

+41.70

127.35

R2

+20.85

106.50

R1

+10.50

96.15

85.65
85.65
Pivot Point
LTP: 82.17

S1

-10.35

75.30

S2

-20.85

64.80

S3

-41.70

43.95

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    82.09

  • 20-EMA

    84.04

  • 30-EMA

    85.65

  • 50-EMA

    89.17

  • 100-EMA

    97.91

  • 200-EMA

    116.11

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
13 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
19 Aug 2025agm
05 Aug 2025dividendFinal Dividend - Rs. - 0.505 Sept 2025
04 Aug 2025dividendDividend - Re 0.50 Per Share05 Sept 2025
20 May 2025dividend₹0.50 Dividend /Share05 Sept 2025
12 Jun 2024dividendAnnual General Meeting/Dividend - Rs 0.50 Per Share15 Jul 2024
14 May 2024dividend₹0.50 Dividend /Share15 Jul 2024
14 May 2024agm
10 Sept 2023splitStock Split From Rs.10 to Rs.110 Oct 2023

Read More

Peer Comparison

Themis Medicare Ltd logo

Themis Medicare Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Themis Medicare Ltd About

Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products especially in Formulation and API activity.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1969

Headquarters

CEO

Dinesh S Patel

Employees

Contact

Website icon

Website

http://www.themismedicare.com

Email icon

Email

sangameshwar.iyer@themismedicare.com; cfoassist@th

Phone icon

Phone

91-260-2421675

Location icon

Location

Plot No 69 A GIDC Indl Estate, Vapi, Valsad, Gujarat, 396195

Read More

Themis Medicare Ltd Company History

YearHistory
2011
  • Themis Medicare introduced a 'calcium' preparation with fruity gummies for pediatric use under the brand name 'THEMIBEAR'.
  • Themis Medicare introduced a 'Multivitamin' for pediatric use under the brand name 'THEMIBEAR'.
  • Themis Medicare launched the brand LUMIXYL, entering the COSMETO-DERMATOLOGY segment.
2013
  • Themis Medicare Limited entered into a License and Supply Agreement with Novartis India Limited to supply Diclofenac topical gel.
  • Themis Medicare Ltd entered into a Supply & Distribution Agreement with Novartis India Ltd to supply Diclofenac Sodium 75mg per ml Injection.
2014
  • Themis invented Aquadol Spass 1ml Injection and commenced production, marketing, and sales.
2022
  • Inosine Pranobex, a unique Immunomodulator drug, received use approval from The Drug Controller General of India for the treatment of COVID-19.
2023
  • The Company has split its face value from Rs. 10/- to Rs. 1/-.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
NK SECURITIES RESEARCH PRIVATE LIMITEDBuy685949141.6109 Oct 2025
GRAVITON RESEARCH CAPITAL LLPBuy659356141.3209 Oct 2025
GRAVITON RESEARCH CAPITAL LLPSell659356141.6309 Oct 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDSell685949141.7209 Oct 2025
TEJAS TRADEFIN LLPBuy72009735.7602 Jun 2021
GAGANDEEP CREDIT CAPITAL PRIVATE LIMITEDSell11250060.2512 Mar 2013
ANUJ ANANTRAI SHETHBuy11250060.2512 Mar 2013
THEMIS DISTRIBUTORS PVT. LTD.Buy234612181.526 Mar 2010
KISHORCHAND RATULSIDAS LAKDAWALASell235712181.526 Mar 2010
DINESH SHANTILAL PATELBuy24171217504 Mar 2010

Read More

Themis Medicare Ltd News

Themis Medicare Issues Corrigendum to Postal Ballot

Themis Medicare Limited issues corrigendum to postal ballot notice dated 25th February 2026, revising warrant issue price from Rs. 100 to Rs. 102.87 per warrant following NSE observations.

10 Mar 2026

co actions results

Themis Medicare Approves Preferential Warrant Issue

Themis Medicare's committee approved allotment of 45,95,795 convertible equity warrants to Vividhmargi Investments at Rs. 100 per warrant, with postal ballot scheduled from February 26 to March 27, 2026.

25 Feb 2026

co actions results

Themis Medicare CS & Compliance Officer Resigns

Themis Medicare Limited announces resignation of Company Secretary and Compliance Officer Pradeep M. Chandan effective February 13, 2026, citing other professional commitments.

14 Feb 2026

stocks

Themis Medicare Allots 60,000 Shares Under ESOP

Themis Medicare Limited allotted 60,000 equity shares under its Employee Stock Option Scheme 2012, increasing paid-up share capital from 9.20 crores to 9.21 crores shares.

11 Dec 2025

co actions results

Themis Medicare Reports Q2 FY26 Results with 31% API Business Growth Despite Formulations Headwinds

Themis Medicare reported consolidated revenue of Rs 78 crore for Q2 FY26 with API business growing 31% year-on-year in H1 FY26, while facing disruption in a high-margin major business line under regulatory investigation. The company expects positive development on the regulatory matter by March 2026 and continues focusing on hospital business expansion and operational efficiency improvements.

13 Nov 2025

earnings

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800